Dataset Information


Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Cote d'Ivoire.

ABSTRACT: BACKGROUND:Cervical cancer incidence is high among women living with HIV due to high-risk HPV persistence in the cervix. In low-income countries, cervical cancer screening is based on visual inspection with acetic acid. Implementing human papilloma virus (HPV) screening through self-sampling could increase women's participation and screening performance. Our study aims to assess the preintervention acceptability of HPV screening among HIV-infected women in Abidjan, Côte d'Ivoire. METHODS:Applying the Health Belief Model theoretical framework, we collected qualitative data through in-depth interviews with 21 HIV-infected women treated in an HIV-dedicated clinic. Maximum variation sampling was used to achieve a diverse sample of women in terms of level of health literacy. Interviews were recorded and transcribed with the participants' consent. Data analysis was performed using NVivo 12. RESULTS:Screening acceptability relies on cervical cancer representations among women. Barriers were the fear of diagnosis and the associated stigma disregard for HIV-associated health conditions, poor knowledge of screening and insufficient resources for treatment. Fees removal, higher levels of knowledge about cervical cancer and of the role of HIV status in cancer were found to facilitate screening. Healthcare providers are obstacle removers by their trusting relationship with women and help navigating through the healthcare system. Self-confidence in self-sampling is low. CONCLUSIONS:Free access to cervical screening, communication strategies increasing cervical cancer knowledge and healthcare provider involvement will foster HPV screening. Knowledge gathered through this research is crucial for designing adequate HPV-based screening interventions for women living with HIV in this setting.


PROVIDER: S-EPMC7385896 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5529114 | BioStudies
2014-01-01 | S-EPMC4198132 | BioStudies
2019-01-01 | S-EPMC6337790 | BioStudies
1000-01-01 | S-EPMC4135323 | BioStudies
1000-01-01 | S-EPMC5311459 | BioStudies
2014-01-01 | S-EPMC4215919 | BioStudies
2021-01-01 | S-EPMC7835166 | BioStudies
1000-01-01 | S-EPMC3919018 | BioStudies
2020-01-01 | S-EPMC7556552 | BioStudies
2016-01-01 | S-EPMC4808515 | BioStudies